Leveraging lessons learned from the COVID-19 pandemic for HIV

被引：2

作者：

Calder, Thomas ^{[1
]}

Tong, Tina ^{[1
]}

Hu, Dale J. ^{[1
]}

Kim, Jerome H. ^{[2
]}

Kotloff, Karen L. ^{[3
]}

Koup, Richard A. ^{[1
]}

Marovich, Mary A. ^{[1
]}

McElrath, M. Juliana ^{[4
]}

Read, Sarah W. ^{[1
]}

Robb, Merlin L. ^{[5
]}

Renzullo, Philip O. ^{[1
]}

D'Souza, M. Patricia ^{[1
]}

机构：

[1] NIAID, NIH, Bethesda, MD 20892 USA

[2] Int Vaccine Inst, Seoul, South Korea

[3] Univ Maryland, Sch Med, Baltimore, MD USA

[4] Fred Hutchinson Canc Res Ctr, Seattle, WA USA

[5] Walter Reed Army Inst Res, Silver Spring, MD USA

来源：

COMMUNICATIONS MEDICINE | 2022年 / 2卷 / 01期

基金：

美国国家卫生研究院;

关键词：

VACCINE EFFICACY; ALVAC;

D O I：

10.1038/s43856-022-00175-8

中图分类号：

R-3 [医学研究方法]; R3 [基础医学];

学科分类号：

1001 ;

摘要：

The rapid development of COVID-19 vaccines and their deployment in less than a year is an unprecedented scientific, medical, and public health achievement. This rapid development leveraged knowledge from decades of HIV/AIDS research and advances. However, the search for an HIV vaccine that would contribute to a durable end to the HIV pandemic remains elusive. Here, we draw from the US government experience and highlight lessons learned from COVID-19 vaccine development, which include the importance of public-private partnerships, equitable inclusion of populations impacted by the infectious pathogen, and continued investment in basic research. We summarize key considerations for an accelerated and re-energized framework for developing a safe and efficacious HIV vaccine.

引用

页数：8

共 50 条

[1] Leveraging lessons learned from the COVID-19 pandemic for HIV
Thomas Calder
Tina Tong
Dale J. Hu
Jerome H. Kim
Karen L. Kotloff
Richard A. Koup
Mary A. Marovich
M. Juliana McElrath
Sarah W. Read
Merlin L. Robb
Philip O. Renzullo
M. Patricia D’Souza
[J]. Communications Medicine, 2
[2] Lessons learned from the COVID-19 pandemic
van Ginneken, Ewout
Webb, Erin
Maresso, Anna
Cyluson, Jonathan
[J]. HEALTH POLICY, 2022, 126 (05) : 348 - 354
[3] Lessons learned from the COVID-19 pandemic
Khoo, Erwin J.
Lantos, John D.
[J]. ACTA PAEDIATRICA, 2020, 109 (07) : 1323 - 1325
[4] Lessons learned from the COVID-19 pandemic
Boulais, Amelie
Boulais, Amélie
[J]. Manufacturing Chemist, 2021, 92 (7-8): : 26 - 29
[5] COVID-19 pandemic: "lessons learned"
Berner, Reinhard
[J]. MONATSSCHRIFT KINDERHEILKUNDE, 2023, 171 (07) : 580 - 583
[6] Lessons learned from the COVID-19 pandemic Foreward
Busse, Reinhard
Muscat, Natasha Azzopardi
de la Mata, Isabel
Figueras, Josep
[J]. HEALTH POLICY, 2022, 126 (05) : 347 - 347
[7] Lessons learned from the COVID-19 pandemic (to date)
Harvey, Edward J.
[J]. CANADIAN JOURNAL OF SURGERY, 2021, 64 (01) : E109 - E110
[8] Lessons learned from Korea: COVID-19 pandemic
Moradi, Hazhir
Vaezi, Atefeh
[J]. INFECTION CONTROL AND HOSPITAL EPIDEMIOLOGY, 2020, 41 (07): : 873 - 874
[9] COVID-19-Pandemie: „lessons learned“COVID-19 pandemic: lessons learned
Reinhard Berner
[J]. Monatsschrift Kinderheilkunde, 2023, 171 (7) : 580 - 583
[10] Lessons learned responding to the COVID-19 pandemic
Sick-Samuels, Anna C.
[J]. INFECTION CONTROL AND HOSPITAL EPIDEMIOLOGY, 2021, 42 (04): : 490 - 491

← 1 2 3 4 5 →